ScopusElsevier Scopus
Status
Active
Coverage
1999–present
Source type
Journal
Open access
No
CiteScore
4.8
Best quartile
Q2 · 61st pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology (medical) | 107 / 278 | 61st | Q2 |
| Pharmacology | 154 / 328 | 53rd | Q2 |
Expert Opinion on Pharmacotherapy
ISSN 1465-6566 · 1744-7666
Publisher: Taylor and Francis Ltd.
Scopus · Q2WoS · SCIEONOS
Is Expert Opinion on Pharmacotherapy indexed in Scopus? Yes — actively indexed in Scopus, coverage 1999–present, best quartile Q2, CiteScore 4.8.
What is the impact factor of Expert Opinion on Pharmacotherapy? Expert Opinion on Pharmacotherapy is indexed in the Science Citation Index Expanded, so Clarivate publishes a Journal Impact Factor for it in the Journal Citation Reports. JCR is a paid Clarivate product, so the JIF value is not free to republish. Its closest free equivalent is the Scopus CiteScore 4.8, which places it in quartile Q2 at the 61st percentile of its subject.
Is Expert Opinion on Pharmacotherapy in Web of Science? Yes — indexed in the Science Citation Index Expanded.
Is Expert Opinion on Pharmacotherapy open access? No — it is not registered as an open-access journal in DOAJ or Scopus.
4.8
CiteScore 2025
Scopus
Q2
Best quartile
rank 107 of 278 · 61st pctile
2
Indexed in
major indexes
Cost to publish: No APC data — check the publisher
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
ABDCAustralian Business Deans Council 2025
Not listed in ABDC.
DOAJDirectory of Open Access Journals (live)
Not in DOAJ
Open accessNot registered as fully open access
FT50Financial Times research list
Not listed in FT50.
UT DallasUTD top-100 business research
Not listed in UT Dallas.
ONOS · SubscriptionOne Nation One Subscription — full-text access
This journal is part of the ONOS national subscription — readers at an ONOS-subscribed Indian institution get full-text access to its articles at no cost.
Access depends on your institution’s ONOS participation; the subscribed title list is subject to revision.
Learn about ONOS ONOS · APC coveredOne Nation One Subscription (Govt of India)
Not in the ONOS APC-supported list.
Publishing in this journal is not centrally APC-funded under One Nation One Subscription.
Official sources & links
Related journals
- Expert Opinion on Therapeutic Patents
- Expert Opinion on Therapeutic Targets
- Expert Review of Anti-Infective Therapy
- Expert Review of Anticancer Therapy
- Expert Review of Cardiovascular Therapy
- Expert Review of Clinical Immunology
- Expert Review of Clinical Pharmacology
- Expert Review of Endocrinology and Metabolism
Explore this journal in the interactive dashboard →
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.